Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Niyuri Fleming
Administrator, NCTN and Compliance
Cancer Center Division
Overview
Research
More
Collaboration
(7)
Jennifer Segar
Mutual work: 4 Proposals﹒2 Grants
Collaboration Details
Fernanda Sanchez Borchardt
Mutual work: 2 Grants﹒4 Proposals
Collaboration Details
Carolyn Lane
Mutual work: 5 Proposals﹒2 Grants
Collaboration Details
Sima Ehsani Chimeh
Mutual work: 3 Proposals
Collaboration Details
Sylvia DeCero
Mutual work: 2 Grants﹒5 Proposals
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(2)
A Phase 1/2, Open Label, Dose-Escalation Study Of Oral ORIN1001 With And Without Chemotherapy In The Treatment Of Subjects With Solid Tumors
Active
·
2022
·
$0 / $245.9K
·
External
oncology,
clinical trial,
chemotherapy,
solid tumors,
dose escalation
A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Patients with Metastatic Breast Cancer (mBCA) Who Have Progressed Through Prior Hormonal Therapy
Active
·
2022
·
$0 / $185.5K
·
External
cancer immunotherapy,
metastatic breast cancer,
immunotherapy combinations,
hormone therapy resistance
